{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:32:06Z","timestamp":1759602726207,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170494","81470320"],"award-info":[{"award-number":["81170494","81470320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bbrc.2017.04.144","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T14:17:08Z","timestamp":1493389028000},"page":"868-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-\u03baB signaling"],"prefix":"10.1016","volume":"487","author":[{"given":"Qinghua","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7346-1332","authenticated-orcid":false,"given":"Yan","family":"Sai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuefeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Tse","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.04.144_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-08-303495","article-title":"Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib","volume":"119","author":"Kumari","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.04.144_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11864-013-0234-8","article-title":"Chronic myeloid leukemia: overview of new agents and comparative analysis","volume":"14","author":"Jain","year":"2013","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2017.04.144_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcmd.2014.02.008","article-title":"ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance","volume":"53","author":"Ferreira","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbrc.2017.04.144_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/ijlh.12351","article-title":"Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"37","author":"Fallah","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.critrevonc.2009.05.001","article-title":"MicroRNA and leukemia: tiny molecule, great function","volume":"74","author":"Zhao","year":"2010","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib7","doi-asserted-by":"crossref","first-page":"695754","DOI":"10.1155\/2013\/695754","article-title":"MicroRNAs as haematopoiesis regulators","volume":"2013","author":"Undi","year":"2013","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib8","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1182\/blood-2011-09-378687","article-title":"The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice","volume":"119","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.04.144_bib9","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1073\/pnas.1315365110","article-title":"B-cell malignancies in microRNA Emu-miR-17\u223c92 transgenic mice","volume":"110","author":"Sandhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2017.04.144_bib10","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","article-title":"Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells","volume":"109","author":"Venturini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.04.144_bib11","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00018-013-1545-4","article-title":"NF-kappaB pathways in hematological malignancies","volume":"71","author":"Gasparini","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2017.04.144_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1874467211003030098","article-title":"Transcription factor NF-kappaB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies","volume":"3","author":"Fuchs","year":"2010","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib13","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2014-01-547943","article-title":"IKK-dependent activation of NF-kappaB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1","volume":"123","author":"Hsieh","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.04.144_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11010-014-2253-6","article-title":"DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K\/Akt\/NF-kappaB pathway","volume":"399","author":"Fang","year":"2015","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.bbrc.2017.04.144_bib15","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1007\/s00018-015-1940-0","article-title":"MicroRNA: master controllers of intracellular signaling pathways","volume":"72","author":"Lui","year":"2015","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2017.04.144_bib16","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1093\/nar\/gks521","article-title":"A\u00a0miR-19 regulon that controls NF-kappaB signaling","volume":"40","author":"Gantier","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2017.04.144_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ni.3026","article-title":"A\u00a0microRNA upregulated in asthma airway T cells promotes TH2 cytokine production","volume":"15","author":"Simpson","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib18","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/10428190310001657326","article-title":"Constitutive NF-kappab\/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)","volume":"45","author":"Munzert","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2017.04.144_bib19","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/emboj.2013.178","article-title":"MicroRNA-17\u223c92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways","volume":"32","author":"Jin","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2017.04.144_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/156800909788486731","article-title":"Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy","volume":"9","author":"Wang","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbrc.2017.04.144_bib21","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1016\/j.ajpath.2014.06.024","article-title":"miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6\/Stat3 as upstream activator","volume":"184","author":"Zhu","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2016.09.011","article-title":"MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells","volume":"46","author":"Jablonska","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib23","doi-asserted-by":"crossref","first-page":"e00822","DOI":"10.7554\/eLife.00822","article-title":"A\u00a0component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis","volume":"2","author":"Olive","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.bbrc.2017.04.144_bib24","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1093\/nar\/gks175","article-title":"MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia","volume":"40","author":"Ye","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2017.04.144_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/978-1-4939-2422-6_29","article-title":"Assessment of canonical NF-kappaB activity in canine diffuse large B-cell lymphoma","volume":"1280","author":"Gaurnier-Hausser","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2017.04.144_bib26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ijc.25497","article-title":"Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL","volume":"128","author":"Philipp","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2017.04.144_bib27","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1038\/cddis.2014.495","article-title":"Nuclear factor-kappaB sensitizes to benzyl isothiocyanate-induced antiproliferation in p53-deficient colorectal cancer cells","volume":"5","author":"Abe","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2017.04.144_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1126\/science.1182364","article-title":"Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes","volume":"327","author":"Shembade","year":"2010","journal-title":"Science"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17308264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17308264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T04:23:44Z","timestamp":1535862224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17308264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0006291X17308264"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.04.144","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.04.144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}